Infection of nearly every ocular structure can result in vision loss, but none is more dreaded than an intraocular infection following a commonly performed procedure such as cataract extraction. While modern methods of asepsis have markedly reduced the incidence of ocular infections in general, postoperative endophthalmitis can occur as an unexpected complication in a variety of clinical settings. Accurate statistics are difficult to obtain, but the incidence of acute postoperative endophthalmitis following cataract extraction has been reported to vary from 0.1% to 0.4%.1 2 Although the incidence is low, the potentially devastating nature of this surgical complication on useful vision merits continued effort towards both prevention and treatment.
Irrespective of the location of the infection, proper antiinfective management requires that the agents selected exhibit maximal efficacy against the causative microbes and minimal toxicity to host tissues. This The subconjunctival route is often used for prophylactic administration of antimicrobial agents following ocular surgery. The study on comparative intraocular penetration of topical and injected cefuroxime in the current issue of the BJO (Jenkins et al, p 685) indicates that subconjunctival, peribulbar, and topical application in the presence of a corneal wound can result in significant aqueous concentrations of the second generation cephalosporin, cefuroxime. Aqueous levels achieved were both dose and time dependent, with maximal concentration between 80 and 110 minutes with peribulbar injection. At this point the aqueous levels in patients given subconjunctival injections were still rising, reaching a maximum between 120 and 160 minutes. If the aqueous level of cefuroxime required for prophylaxis is equivalent to the MICG90 value of 8 The question of clinical effectiveness of subconjunctival antibiotics remains a matter of conjecture. If subconjunctival administration at the end of surgery decreases the incidence of endophthalmitis, the question to answer is which drug or combination of drugs has the best risk-benefit ratio? Perhaps Leopold and Apt stated it best when they noted more than 30 years ago that prophylactic antibiotic use by subconjunctival route to prevent postoperative infections 'will be proven only as a consequence of a controlled study both instituted 
